UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~January~~February 171, ~~2011~~2013

AVICENNA GLOBAL CORP.

(Exact name of registrant as specified in charter)

Nevada	333-164454	80-0347923
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

No 4/1062A, Beach Road, Calicut Kerala, India	673032
#205A - 9003 Reseda Blvd., Northridge, California	91324
(Address of principal executive offices)	(Zip Code)

~~+91~~(818) ~~495 401 4357~~472-7722

~~Registrant~~Company’s telephone number

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

Item 15.0102. Departure ~~Entry~~of ~~Into~~Directors aor ~~Material~~Certain ~~Definitive~~Officers; ~~Agreement~~Election of Directors; Appointment of Certain Officers.

On ~~January~~February 171, ~~2011~~2013, Avicenna Global Corp. (the “Company”) ~~entered~~received ~~into~~ a ~~Memorandum~~Notice of ~~Understanding~~Resignation ~~(the~~from ~~“MOU”)~~Ummer ~~with~~Veedu ~~KKT~~as ~~International~~President, ~~Ltd.~~CEO, ~~(“KKT”). KKT~~Principal ~~has~~Executive ~~acquired~~Officer, orTreasurer, ~~developed~~CFO, aPrincipal ~~body~~Accounting ofOfficer, ~~knowledge~~Treasurer, ~~pertaining~~Chairman ~~to therapeutic and diagnostic treatment~~ of the ~~spine. The~~Board ~~MOU~~of ~~states~~Directors ~~that~~and ~~the~~as ~~Company will work with KKT to develop clinics using KKT’s technologies in Mumbai, India~~Director.

~~Item~~On ~~5.02.~~February ~~Departure~~1, 2013, the Company, pursuant to a special vote by written consent of ~~Directors~~the ormajority ~~Certain~~of ~~Officers;~~its ~~Election~~shareholders, appointed Vikram Khanna as President, CEO, Principal Executive Officer, Treasurer, CFO, Principal Accounting Officer, Treasurer, Chairman of ~~Directors;~~the ~~Appointment~~Board of ~~Certain~~Directors ~~Officers~~and as Director.

OnMr. ~~January~~Khanna ~~28,~~has ~~2011,~~been ~~the~~President ~~Company,~~and ~~pursuant~~C.E.O. toof aPanascope ~~special~~Capital ~~vote~~since byJanuary ~~written~~2008. Mr. ~~consent~~Khanna ofhas ~~the~~successfully ~~majority~~traded ofand ~~its~~invested ~~shareholders,~~in ~~appointed Dr. Aslam Khan~~stocks, ~~Afnaz~~options, ~~Abootty~~precious ~~Ahamed~~metals and ~~Jawad~~currencies ~~Qureshi~~and toprovided ~~its~~consultant ~~Board~~services offor ~~Directors. The~~various ~~appointment~~private ~~of Messrs. Khan, Ahamed~~ and ~~Qureshi~~public ~~brings the number of directors sitting on the Company’s Board of Directors to five~~companies.

~~For the past 15 years, Dr~~Mr. ~~Aslam~~Khanna ~~Khan~~will ~~has~~serve ~~been~~as ~~the~~our ~~founder~~director and ~~creative~~officer ~~visionary~~until ~~behind~~his ~~the~~duly ~~revolutionary~~elected ~~non-invasive~~successor ~~KKT~~is ~~spine~~appointed ~~treatment. As~~or ~~the~~he ~~founder,~~resigns. There ~~CEO~~are ~~and~~no ~~chairman~~arrangements ofor ~~KKT~~understandings ~~International,~~between DrMr. ~~Khan~~Khanna ~~has been involved in the research~~ and ~~development~~any ofother ~~KKT~~person ~~treatment~~pursuant ~~technology~~to ~~and~~which ~~managing~~he ~~the~~was ~~company’s~~selected ~~operations~~as ~~around~~an ~~the~~officer ~~globe~~or ~~including~~director. There ~~Canada,~~are ~~Thailand,~~no ~~Taiwan,~~family ~~Germany,~~relationship ~~the~~between ~~Middle~~Mr. ~~East~~Khanna and ~~India. Dr.~~any ~~Khan~~of ~~has~~our ~~co-authored~~officers ~~several~~or ~~research articles that have been published in peer-reviewed medical journals such as “Spine”~~directors. Dr Mr. ~~Khan~~Khanna ~~and his research~~ has ~~determined~~not ~~that~~held ~~tissue~~any ~~regeneration~~other ~~and~~directorships ~~bio-synthesis activation offer new opportunities~~ in ~~medical~~a ~~research~~company ~~and has focused his collaborations~~ with ~~other~~a ~~world~~class ~~renown~~of ~~researchers~~securities ~~specifically~~registered inpursuant ~~this~~to ~~area. Dr.~~section ~~Khan~~12 ~~has~~of ~~developed~~the ~~new~~Exchange ~~diagnostic~~Act ~~analysis~~or ~~applications,~~subject ~~exercise~~to ~~programs~~the ~~and~~requirements ~~spine~~of ~~related~~section ~~medical~~15(d) ~~services~~of ~~and~~such ~~products. Dr.~~Act ~~Khan~~or ~~has~~any ~~been~~company ~~nominated~~registered ~~for~~as ~~several~~an ~~innovation~~investment ~~and~~company ~~medical~~under ~~breakthrough~~the ~~awards~~Investment ~~both~~Company ~~locally~~Act ~~and~~of ~~internationally~~1940.

~~Mr.~~On ~~Afnaz~~February ~~Ahamed~~1, ~~has~~2013, ~~12 years of experience in managing and leading multimillion dollar IT projects in~~ the ~~Middle~~Company ~~East~~received ~~primarily~~a inNotice ~~the~~of ~~U.A.E. His~~Resignation ~~experience range~~ from ~~various~~Tariq ~~industries such as airline~~Tyab, ~~media~~Dr. &Aslam ~~broadcast~~Khan, ~~financial~~Afnaz ~~institution~~Abootty ~~and~~Ahamed ~~governmental bodies. He has worked in a leadership capacity to manage~~ and ~~deliver~~Jawad ~~critical~~Qureshi ~~projects~~as ~~for~~Directors ~~several government agencies. From 2009 to present he is the Projects & Services Director at Securetech LLC in the U.A.E. where he heads the organization service delivery~~ and ~~enterprise projects business unit. From 2005 to 2009 Mr. Ahamed was a Technical Arichetect at ESCA~~ in ~~the~~all ~~U.A.E. At~~positions ~~ESCA~~that ~~Mr.~~they ~~Ahamed~~held ~~was~~with ~~responsible for designing and implementing~~ the ~~IT services infrastructure~~Company.

~~From~~With ~~June~~these ~~2010~~resignations todisclosed ~~present~~above, ~~Mr.~~the ~~Jawad~~number ~~Qureshi has served as President Of Simple Q Management Inc. where he assisted companies that were private and publically traded with his vast experience in areas~~ of ~~corporate~~directors ~~restructuring,~~sitting ~~capital~~on ~~formation and corporate finance in~~ the USCompany’s ~~stock~~Board ~~markets. From~~of ~~2003~~Directors ~~until~~has ~~June~~been ~~2010~~reduced ~~Mr. Qureshi worked at Auto West BMW in various positions,~~ from ~~business~~five ~~development~~ to ~~director of new car sales~~one. ~~In his time at Auto West BMW, Mr. Qureshi was pioneering innovative sales and marketing methods that resulted in continuous organic double digit growth.~~

Messrs. Khan, Ahamed and Qureshi will serve as our Directors until their duly elected successor is appointed or they resign. There are no arrangements or understandings between them and any other person pursuant to which each was selected as a director. There are no family relationship between Messrs. Khan, Ahamed and Qureshi and any of our officers or directors. Messrs. Khan, Ahamed and Qureshi have not held any other directorships in a company with a class of securities registered pursuant to section 12 of the Exchange Act or subject to the requirements of section 15(d) of such Act or any company registered as an investment company under the Investment Company Act of 1940. SIGNATURES

~~SIGNATURES~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~Pursuant~~Date: toMarch ~~the requirements of the Securities Exchange Act of 1934~~4, ~~the~~2014 ~~Registrant~~AVICENNA ~~has~~GLOBAL ~~duly~~CORP. ~~caused~~By:/s/ ~~this~~Ummer ~~report~~Veedu toUmmer beVeedu, ~~signed on its behalf by the undersigned hereunto duly authorized.~~President

		AVICENNA GLOBAL CORP.
Date: February 3, 2011		By: /s/ Ummer Veedu
		Ummer Veedu, President

Filing Compare · AVICENNA GLOBAL CORP.